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Abstract
The intracellular Gram-negative bacterium Francisella tularensis causes the disease tularemia and is known for its ability to
subvert host immune responses. Previous work from our laboratory identified the PI3K/Akt pathway and SHIP as critical
modulators of host resistance to Francisella. Here, we show that SHIP expression is strongly down-regulated in monocytes
and macrophages following infection with F. tularensis novicida (F.n.). To account for this negative regulation we explored
the possibility that microRNAs (miRs) that target SHIP may be induced during infection. There is one miR that is predicted to
target SHIP, miR-155. We tested for induction and found that F.n. induced miR-155 both in primary monocytes/
macrophages and in vivo. Using luciferase reporter assays we confirmed that miR-155 led to down-regulation of SHIP,
showing that it specifically targets the SHIP 39UTR. Further experiments showed that miR-155 and BIC, the gene that
encodes miR-155, were induced as early as four hours post-infection in primary human monocytes. This expression was
dependent on TLR2/MyD88 and did not require inflammasome activation. Importantly, miR-155 positively regulated pro-
inflammatory cytokine release in human monocytes infected with Francisella. In sharp contrast, we found that the highly
virulent type A SCHU S4 strain of Francisella tularensis (F.t.) led to a significantly lower miR-155 response than the less
virulent F.n. Hence, F.n. induces miR-155 expression and leads to down-regulation of SHIP, resulting in enhanced pro-
inflammatory responses. However, impaired miR-155 induction by SCHU S4 may help explain the lack of both SHIP down-
regulation and pro-inflammatory response and may account for the virulence of Type A Francisella.
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Introduction
Francisella tularensis is a highly infectious Gram-negative
bacterium that infects phagocytic cells of the immune system
[1–3]. Exposure to this pathogen causes the disease known as
tularemia and a dose of as few as ten colony forming units can be
lethal to humans [4,5]. Thus, the CDC has classified this pathogen
as a Category A select agent [6]. There are five known subspecies
of Francisella [5,7], and the subspecies novicida (F.n.) is less infectious
to humans than the Type A F. tularensis subspecies tularensis (F.t.).
However, F.n. provides an excellent model organism because it
shares a similar intracellular lifecycle to F.t. and leads to tularemia-
like pathologies in mouse models [4].
Effective host cell defense against Francisella is subverted by
numerous mechanisms. Indeed, interferon response [8], toll-like
receptor (TLR) signaling [9–11], and antigen presentation [11,12]
are all found to be compromised by Francisella. Although Gram-
negative, Francisella presents a modified form of lipopolysaccharide
(LPS) that only minimally activates TLR4 [10,13]. Instead, most
of the cell surface-driven host response is through TLR2 [14,15]
and finding ways to enhance the response are of interest for novel
therapeutics [16]. Understanding these host responses and how
Francisella undermines them is critical for our ability to successfully
prevent and treat infection.
One important response downstream of TLR stimulation is
activation of the PI3K/Akt pathway [17,18]. Our laboratory has
shown that PI3K/Akt activation is host-protective against
Francisella, as mice expressing a macrophage-specific, constitutive-
ly-active form of Akt are protected from an otherwise-lethal
challenge compared to wild-type littermates [18]. Expectedly, the
PLoS ONE | www.plosone.org 1 December 2009 | Volume 4 | Issue 12 | e8508PI3K/Akt pathway is subject to negative regulation and one of the
key regulators is SHIP, which we have also found to be important
during Franciesella infection. Murine bone marrow-derived macro-
phages (BMM) lacking SHIP display increased NFkB activity and
enhanced cytokine production [17], similar to the responses seen
with constitutively active Akt [18]. More recently we have found
that the loss of SHIP or constitutive activation of Akt promotes
phagosome-lysosome fusion of Francisella in macrophages. Thus
this pathway is important for intracellular control [19,20].
Collectively, these findings implicate the PI3K/Akt pathway and
SHIP as critical regulators of the host-response to Francisella.
While studying the role of SHIP during Francisella infection, we
found that infection with the less virulent F.n. leads to SHIP down-
regulation. In a search for mechanisms to explain this, we
entertained the possibility that microRNAs may play a role. In
fact during the preparation of this manuscript it was reported that
SHIP is targeted by a microRNA, miR-155 [21]. MiRs are a
recently-discovered means of regulating both transcript and
protein levels of specific genes [22]. They are processed yet non-
translated RNA molecules of approximately 22 base pairs in length
that primarily target the 39untranslated region (UTR) of mRNA
transcripts in a sequence-specific manner. Recent reports show that
treatment with TLR ligands can induce miR-146 and miR-155
expression within macrophages [23,24]. Yet the significance
of these findings within the context of a bacterial infection
remains largely unknown; however, is of great interest [20].
Here, we show that Francisella infection induces miR-155
expression in a TLR-dependent manner and that this leads to
down-regulation of SHIP. Notably, the less virulent F.n. subspecies
strongly induces miR-155 while the virulent F.t. isolate SCHU S4
does not. Hence, expression of miR-155 is a component of host
defense against Francisella and the difference in miR-155 response
to these two subspecies may help explain the success of F.t. as an
infectious agent in humans.
Results
SHIP Expression Is Down-Regulated in Response to F.n.
Infection
We have previously demonstrated that the pro-inflammatory
cytokine response to Francisella infection requires the activation of
the PI3K/Akt pathway and that this response is down-regulated
by SHIP, an established negative regulator of the PI3K/Akt
pathway [17,18]. To follow up these findings, we examined the
expression of SHIP during F.n. infection. Here, human PBM were
infected with F.n. (MOI 50) for 24 hours and SHIP protein levels
were analyzed by Western blotting. Results, shown in Figure 1A,
demonstrate a dramatic down-regulation of SHIP in infected cells
versus uninfected controls. The lower panel is a reprobe of the
same membrane with actin antibody to ensure equal loading of
protein in both lanes. Of note, viability of PBM at 24 hours post
infection was greater than 90%. Similar down-regulation of SHIP
Figure 1. SHIP expression is down-regulated in response to F.n. infection. (A) PBM were infected with F.n. at an MOI of 50 for 24 hours. Cell
lysates were analyzed by Western blotting use an anti-SHIP antibody in the top panel. ‘R’ designates resting/uninfected cells and ‘24 h’ designates
infected with F.n. The lower panel is a reprobe of the same membrane with an anti-actin antibody. (B) THP-1 were infected with F.n. at an MOI of 100
for 24 hours. Cell lysates were resolved as in Figure 1A. (C) Western blots for SHIP in murine bone marrow-derived macrophages infected with F.n. at
an MOI of 50 for 24 hours. Cell lysates were resolved as in Figure 1A. (D) Predicted interaction between miR-155 and the 39UTR of SHIP (INPP5D)
mRNA. (E) Normalized luciferase activity in cells transfected with the 39UTR of SHIP (psiCHECK_INPP5D) or with vector alone (psiCHECK), and
cotransfected with a control Renilla luciferase vector. Synthetic miR-155 or non-specific (scrambled) miRs were subsequently transfected at
concentrations of 0, 10, 25 and 50 nM. Luminometer readings were taken 48 hours post-transfection. The graph represents f-luc expression
normalized to r-luc expression, then normalized to percent maximal response.
doi:10.1371/journal.pone.0008508.g001
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(Figure 1B), as well as in primary murine bone marrow-derived
macrophages (BMM) (Figure 1C) infected with F.n. for 24 hours at
an MOI of 100 and 50, respectively.
In a search for potential mechanisms responsible for this down-
regulation, we explored the possibility that microRNAs (miRs)
may be involved. We used the online bioinformatics program
TargetScan (http://www.targetscan.org) to identify potential miRs
that may regulate SHIP. The program identified miR-155 as the
sole predicted miR to bind SHIP on its 39 UTR (Figure 1D). To
assess the ability of miR-155 to specifically target the 39UTR of
SHIP we performed dual-luciferase reporter assays. For this, an f-
luc luciferase reporter alone (psiCHECK) or the same reporter
with the 39UTR of SHIP (psiCHECK-INPP5D) were separately
transfected into chinese hamster ovary (CHO) cells using
Lipofectamine 2000. To control for differences in transfection
efficiency a pRL-CMV Renilla luciferase construct was co-
transfected with the psiCHECK vectors. To test the effect of
miR-155 on expression of the transfected SHIP 39 UTR reporter,
synthetic miR-155 or scrambled miR were co-transfected into the
cells at concentrations ranging from 10 nM to 50 nM. At 48 hours
post-transfection cells were washed and lysed. Dual-luciferase
activity in the transfectants was then measured. As shown in
Figure 1E, the introduction of miR-155 suppressed the luciferase
activity of psiCHECK-INPP5D but not of psiCHECK alone,
indicating that miR-155 targeted the 39 UTR of SHIP. As an
additional control, cells were transfected with psiCHECK-
INPP5D followed by a scrambled miR, and these showed no
decrease in luciferase production.
MiR-155 Is Induced In Vitro and In Vivo in Response to
F.n. Infection
Having established that SHIP is down-regulated during F.n.
infection and that miR-155 is a negative regulator of SHIP, we
next examined whether mature miR-155 and BIC, the non-protein
coding gene that encodes miR-155 [25], mRNA were induced in
infected cells. For this, human PBM were infected with F.n. and
the expression of miR-155 and BIC were measured by qRT-PCR.
Results showed a dose-dependent induction of mature miR-155
(Figure 2A) as well as BIC (Figure 2B) in PBM infected at MOI 1,
10, or 50 for 24 hours. We next examined the time course of miR-
155 and BIC induction. Results showed a gradual increase in both
mature miR-155 (Figure 2C) and BIC mRNA (Figure 2D) from 4
to 24 hours post-infection when infected at an MOI of 50. This
time course of mature miR-155 induction is consistent with
previous findings in murine macrophages stimulated with toll-like
receptor ligands [24].
Next, we tested whether F.n. infection led to miR-155 induction
in vivo. For this, mice were challenged with 200 CFU of F.n. or
with PBS, delivered intraperitoneally. The animals were sacrificed
at 24, 48, and 72 hours post-infection (n=6 per time point) and
the lungs, liver, and spleen were harvested. RNA from
homogenates was assayed for mature miR-155 by qRT-PCR
(Figure 2E). Tissue-specific patterns of miR-155 matched those
previously reported [26], where basal relative expression was
highest in the spleen and lowest in the liver. Results showed a clear
F.n.-induced induction of miR-155 in all organs tested, suggesting
that F.n. elicits expression of mature miR-155 in vivo.
Bacterial Viability Contributes to MiR-155 Induction
Since infection with F.n. induces miR-155, we next tested
whether bacterial viability was required for this response. PBM
were infected with live, paraformaldehyde-killed or heat-killed F.n.
at an MOI of 50 for 24 hours. While both forms of killed bacteria
were able to induce relative miR-155 levels above that of
uninfected cells, the levels were lower than what is induced by
live bacteria (Figure 3A). To gain a better understanding of why
viability is important, we examined miR-155 levels after 24 hours
in PBM either exposed to 50 MOI of F.n. for the full 24 hour
period or exposed for 2 hours before removal of extracellular
bacteria. The PBM exposed to F.n. for the full 24 hours showed a
stronger induction in miR-155 than those exposed for only
Figure 2. miR-155 is induced in vitro and in vivo in response to F.n. infection. (A–B) PBM were infected with F.n. for 24 hours at an MOI of 1,
10, or 50. Relative miR-155 (A) and BIC (B) expression were measured by qRT-PCR and then converted to fold change over uninfected. (C–D) PBM were
infected with F.n. at an MOI of 50 for 4, 8, or 24 hours. Relative miR-155 (C) and BIC (D) expression were measured by qRT-PCR and then converted to
fold change over uninfected. Graphs represent the mean and standard deviation of samples from three independent infections. (E) Mice were
injected peritoneally with 200 CFU of F.n. or PBS, then euthanized at 24, 48, and 72 hours post-infection. Relative miR-155 expression was measured
by qRT-PCR for the liver, lung and spleen and then converted to fold change over uninfected. An n of 6 was used for each timepoint. Graphs
represent the mean and standard deviation. Data were analyzed by a paired Student t test. An asterisk (*) indicates a p-value,0.05.
doi:10.1371/journal.pone.0008508.g002
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killed bacteria were comparable between the continuous exposure
and the 2-hour exposure. These results suggest that a single
exposure to F.n. induces miR-155, but that continuous infection
elicits higher levels. These results also help explain Figures 2C and
2D, where the highest level of miR-155 was seen at 24 hours.
MiR-155 Induction by F.n. Requires Activation of the TLR
Signaling Pathway
Previous studies have determined that TLR2 is critical for the
recognition of Francisella and induction of the pro-inflammatory
response. To test the involvement of TLR signaling in miR-155
induction we infected bone marrow-derived macrophages (BMM)
from either wild-type or MyD88
2/2 mice with F.n. at an MOI of
50 for 24 hours. Wild-type macrophages showed strong induction
of miR-155, whereas the miR-155 response in MyD88
2/2
macrophages was drastically reduced (Figure 3C). Confirming
the absence of MyD88, we found that TNFa was not secreted by
the MyD88
2/2 macrophages following infection (Figure 3D) as
should be expected given that TNFa induction is entirely TLR2-
and MyD88-dependent [14]. Hence, miR-155 induction by F.n. is
MyD88-dependent.
To further test the role of TLR signaling in the induction of
miR-155 we infected wild-type and TLR2 signaling mutant
macrophages with F.n. at an MOI of 50 for eight hours. The
results show that TLR2 is required for the induction of miR-155
(Figure 3E). As a control for the TLR2 signaling mutant we tested
for signaling activation of the NFkB pathway. It is clear that the
TLR2 signaling mutant functions as expected since these
macrophages do not display activation of the IKK complex or
lead to NFkBp65 phosphorylation whereas the wild-type do
(Figure 3F).
We next tested the involvement of PI3K and the mitogen-
activated protein kinases (MAPKs), downstream mediators known
Figure 3. Bacterial viability contributes to miR-155 induction through the TLR pathway. (A) PBM were infected with live, heat-killed (HK),
or paraformaldehyde-fixed (PFA) F.n. at an MOI of 50 for 24 hours, then miR-155 measured by qRT-PCR. (B) PBM were infected with live F.n. or heat-
killed F.n. at an MOI of 50, then with or without gentamicin after 2 hours, then miR-155 was assayed by qRT-PCR. (C) Wild-type (WT) or MyD88
2/2
bone marrow-derived macrophages were infected with F.n. at an MOI of 50 for 24 hours, then relative miR-155 expression measured by qRT-PCR and
then converted to fold change over uninfected. (D) ELISA for TNFa secretion in supernatants from the samples in Figure 3C. (E) Wild-type (WT) and
TLR2 (TLR2 Mut) signaling mutant bone marrow-derived macrophages were infected with F.n. at an MOI of 50 for eight hours and miR-155 was
assayed by qRT-PCR. (F) WT and TLR2 Mut macrophages were infected at an MOI of 50 of F.n. for 5, 20, 40, and 60 minutes. Cell lysates were analyzed
by Western blotting for pIKKa, pNFkBp65, and Actin. (G) PBM were pretreated for 30 minutes with inhibitors of PI3K (LY), ERK (UO), JNK (SP), p38 (SB),
or with DMSO vehicle control, infected with F.n. at an MOI of 50 for 6 hours, then miR-155 was assayed by qRT-PCR. (H) PBM were pretreated with the
IKK inhibitor BAY7085 (BAY) or DMSO vehicle control for 90 minutes, infected with F.n. at an MOI of 50 for 6 hours, then miR-155 was assayed by qRT-
PCR. (I) ELISA for TNFa in supernatants from the samples in Figure 3F. All experiments were performed in triplicate, and each experiment performed
three times. Graphs represent mean and standard deviation. Data were analyzed by a paired Student t test. An asterisk (*) indicates a p-value,0.05.
doi:10.1371/journal.pone.0008508.g003
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pretreated with LY294002 (PI3K inhibitor), U0126 (ERK
inhibitor), SP00125 (JNK inhibitor), SB203580 (p38 inhibitor) or
DMSO vehicle control for 30 minutes and then infected with F.n.
for 6 hours at an MOI of 50. Inhibition of PI3K completely
blocked miR-155 induction (Figure 3G). An earlier report in B
cells showed that the MAPKs ERK and JNK but not p38 were
necessary for miR-155 induction by B-cell receptor activation
[27]. Consistent with this, we found that inhibition of both ERK
and JNK resulted in reduced miR-155 induction but inhibition of
p38 showed no effect. Given these results we can conclude that
miR-155 induction in response to F.n. requires the downstream
activation of PI3K, ERK, and JNK.
NFkB is a critical mediator of TLR signaling as well as a myriad
of other cellular responses [28,29]. However, its role in miR-155
induction is unclear with one report showing that it was essential
[30] but another concluding that it was not [27]. We surmised that
its involvement could be dependent upon the nature of the
stimulus, so we examined the role of NFkB within the context of
Francisella infection. Here, PBM were pretreated with either the
IkB kinase (IKK) inhibitor BAY7085 or with DMSO vehicle
control for 90 minutes, followed by infection with F.n. at 50 MOI
for 6 hours. As shown in Figure 3H, pretreatment with BAY7085
completely blocked the Francisella-induced miR-155 response. To
verify the efficacy of this NFkB inhibition, TNFa secretion was
measured after Francisella infection with or without pretreatment
with BAY7085. As expected, there was no detectable TNFa
release with BAY7085 pretreatment (Figure 3I). A lactate
dehydrogenase (LDH) assay showed cytotoxicity of less than
10% after incubation with BAY7085 for 8 hours, again confirming
that the cells were viable (data not shown). To confirm the
requirement for NFkB, the peptide inhibitor SN50 was also used
and found to block miR-155 induction (data not shown).
Collectively, these results suggest that Francisella-induced miR-
155 induction requires NFkB activation. This finding helps to
explain why bacterial viability was required for maximal miR-155
induction (Figure 3A&B). A pervious report showed that maximal
NFkB activation in response to F.t. LVS required bacterial
viability and de novo bacterial protein synthesis [14]. Thus killed
bacteria will have suboptimal NFkB activation as compared to live
bacteria, and therefore suboptimal miR-155 induction.
Bacterial Internalization and MiR-155 Induction
Having found that TLR activity through MyD88 was critical for
miR-155 induction, we hypothesized that cell surface contact with
the bacteria would be sufficient to elicit miR-155. To test this, we
pretreated PBM with an actin polymerization inhibitor, cytocha-
lasin-D, or DMSO vehicle control for 30 minutes [31]. PBM were
then infected with an MOI of 50 for 6 hours and miR-155
expression was measured by qRT-PCR (Figure 4A). MiR-155
expression was measured at 6 hours post-infection since the
effectiveness of cytochalasin-D is reduced at later time points.
MiR-155 induction in infected cells was not significantly different
between vehicle control and cytochalasin-D treatments, suggesting
that phagocytosis and internalization of Francisella may not be
required during the early stages of infection for a miR-155
response. To verify the effectiveness of cytochalasin-D, CFU assays
were performed in parallel with the same samples. After removal
of viable extracellular bacteria with gentamicin, host cell lysates
were plated and bacteria counted. Results showed approximately a
3-log reduction in uptake following cytochalasin-D pretreatment
(Figure 4B).
F.n.-Mediated MiR-155 Induction Is Independent of
Caspase-1 Inflammasome Activation
One hallmark of Francisella infection is that the bacteria can
escape from the phagosome into the cytosol within an hour after
internalization [3,32], which leads to inflammasome and caspase-1
Figure 4. Effects of host-cell entry and inflammasome activation on miR-155 induction. (A) PBM were pretreated for 30 minutes with
5 mg/ml cytochalasin D (CytoD), infected with F.n. at an MOI of 50 for 6 hours, then relative miR-155 expression measured by qRT-PCR. (B) CFU assays
were conducted in parallel with the samples from Figure 4A. (C) Wild-type (WT) and caspase-1
2/2 bone marrow-derived macrophages were infected
with F.n. at an MOI of 50 for 8 hours and miR-155 was assayed by qRT-PCR. (D) ELISAs were done to measure IL-1b in supernatants from the samples
in Figure 4C. Graphs represent the mean and standard deviation from three independent infections. Data were analyzed by a paired Student t test.
An asterisk (*) indicates a p-value,0.05.
doi:10.1371/journal.pone.0008508.g004
MiR155 Regulates Host Response
PLoS ONE | www.plosone.org 5 December 2009 | Volume 4 | Issue 12 | e8508activation as well as IL-1b release [33,34]. To test whether
inflammasome activation was required for the induction of miR-
155, we infected wild-type or caspase-1 knockout bone marrow-
derived macrophages with F.n. at an MOI of 50 for 8 hours. MiR-
155 expression was measured by qRT-PCR and it was found that
both the wild-type and caspase-1
2/2 macrophages responded
nearly identical (Figure 4C). Thus, F.n.-induced miR-155
expression is caspase-1-independent, suggesting that the caspase-
1 inflammasome is not required. To verify lack of caspase-1
function in these BMM, IL-1b release was measured. Results
(Figure 4D) showed that, as expected, IL-1b secretion by caspase-
1
2/2macrophages was impaired.
MiR-155 Promotes Pro-Inflammatory Cytokine
Production during F.n. Infection
Activation of the PI3K/Akt pathway promotes the pro-
inflammatory response to F.n., and SHIP is an established negative
regulator of this pathway [35]. We have previously demonstrated
that SHIP
2/2 macrophages display enhanced pro-inflammatory
cytokine production in comparison to wild-type macrophages
infected with F.n. [17]. Given the observations that miR-155 is
strongly induced in response F.n. infection and that miR-155 can
negatively regulate SHIP expression, we hypothesized that miR-
155 exerts its pro-inflammatory function against Francisella by
repressing SHIP. To test the functional consequence of miR-155
expression, PBM were transfected with either exon 3 of BIC
(encoding the mature miR-155) or an empty vector. RNA was
extracted 22 hours after transfection and qRT-PCR for miR-155
expression was performed. Over-expression resulted in an
approximately 3-fold increase in miR-155 compared to vector-
only transfection (Figure 5A). SHIP mRNA was then measured in
the same samples by qRT-PCR, and results showed that miR-155
over-expression alone was sufficient to significantly decrease SHIP
mRNA (Figure 5B). To determine the functional consequence for
F.n. infection, PBM were infected 14 hours after transfection with
F.n. at an MOI of 50 for 8 hours and the secretion of TNFa
(Figure 5C) and IL-6 (Figure 5D) quantified by ELISA. Levels of
both cytokines were significantly enhanced in PBM over-
expressing miR-155 compared to those with vector control.
Results from this over-expression of miR-155 are reflective of the
results seen with SHIP
2/2 macrophages infected with F.n. by
Parsa et al. Collectively, these results are consistent with the
hypothesis that miR-155 promotes pro-inflammatory cytokine
production largely by downregulating SHIP.
To complement the data obtained from miR-155 over-
expression, we tested the function of miR-155 in wild-type versus
miR-155
2/2 macrophages. The loss of miR-155 was verified by
qRT-PCR (Figure 5E). Given that miR-155 targets SHIP, we
Figure 5. miR-155 promotes pro-inflammatory cytokine production during F.n. infection. (A) PBM were transfected with vector control or
miR-155 overexpression construct. 22 hours post-transfection, RNA was extracted and miR-155 over-expression was verified by qRT-PCR. (B) SHIP
expression was assayed from the samples in Figure 5A. (C–D) 14 hours post-transfection PBM were infected with F.n. at an MOI of 50 for 8 hours and
(C) TNFa and (D) IL-6 measured in supernatants. (E) Wild-type and miR-155
2/2 macrophages were assayed for miR-155 expression. (F) SHIP expression
was assayed by qRT-PCR from the samples in Figure 5E. (G) Wild-type and miR-155
2/2 macrophages were infected with F.n. at an MOI of 50 for eight
hours. IL-6 in the supernatant was measured by ELISA. All experiments were performed in triplicate. Graphs represent the mean and standard
deviation of samples from three independent experiments. Data were analyzed by a paired Student t test. An asterisk (*) indicates a p-value,0.05.
doi:10.1371/journal.pone.0008508.g005
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2/2
macrophages. The loss of miR-155 was sufficient to lead to
enhanced SHIP mRNA expression as compared to wild-type
macrophages, further supporting the finding that miR-155 targets
SHIP (Figure 5F). We then tested the pro-inflammatory response
between wild-type and miR-155
2/2 macrophages infected with
F.n. MiR-155
2/2 macrophages had significantly lower IL-6
production as compared to wild-type macrophages (Figure 5G).
Collectively these data show that miR-155 negatively regulates
SHIP and promotes inflammatory cytokine response to F.n.
Virulent F.t. Induces Suboptimal MiR-155 and
Pro-Inflammatory Cytokine Responses
Since we have established that the less virulent F.n. induces
robust miR-155 induction in monocytes/macrophages and that it
can regulate TNFa and IL-6, we next examined whether the miR-
155 response was similar with the highly virulent F.t. isolate
SCHU S4. PBM were infected with F.n. or F.t. for 24 hours.
Relative expression of miR-155 (Figure 6A) and BIC (Figure 6B)
were determined by qRT-PCR. While F.t. SCHU S4 led to
modest miR-155 and BIC expression, it was significantly lower
than that elicited by F.n.
Since miR-155 negatively regulates SHIP, and miR-155
induction is minimal following F.t. infection, we tested the ability
of F.t. to down-regulate SHIP expression. We infected PBM with
F.n. or F.t. for 24 hours. F.n. elicited a stronger miR-155 induction
than F.t. and consistent with this, SHIP down-regulation was seen
with infection by F.n. but not by F.t. (Figure 6C).
In light of these findings, we examined the production of
TNFa and IL-6 in response to F.n. and F.t., which we have now
shown to be regulated by miR-155 and thus should be produced
at lower levels in response to F.t. than to F.n. PBM were infected
at an MOI of 50 for 24 hours and the levels of TNFa (Figure 6D)
and IL-6 (Figure 6E) were determined by ELISA. Concordantly,
it was found that the production of both cytokines was
significantly lower in F.t.-infected samples than F.n.-infected
samples. It is well established that Francisella bypasses or subverts
host responses [11,12], and the lack of miR-155 response after
infection with the virulent str a i nm a yb eak e yc o n t r i b u t i n g
factor.
Figure 6. Virulent F.t. elicits suboptimal miR-155 and pro-inflammatory cytokine responses. (A–B) PBM (n=7) were infected with F.n. or
F.t. at an MOI of 100 for 24 hours. Relative miR-155 (A) and BIC (B) expression were measured by qRT-PCR. (C) PBM were infected with F.n. or F.t. at an
MOI of 50 for 24 hours, then cell lysates probed for SHIP by Western blotting (top panel). The lower panel is a reprobe of the same membrane with
anti-actin antibody. (D–E) PBM were infected with F.n. or F.t. at an MOI of 50 for 24 hours. TNFa (D) and (E) IL-6 in supernatants were measured by
ELISA. Graphs represent the mean and standard deviation of samples from three independent infections. Data were analyzed by a paired Student t
test. An asterisk (*) indicates a p-value,0.05.
doi:10.1371/journal.pone.0008508.g006
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and in vivo by F.n. through the TLR signaling pathway and NFkB
activation; however, this does not require activation of the
inflammasome. Intriguingly we found that the highly virulent
F.t. leads to minimal induction of miR-155 as well as a lack of
ability to downregulate SHIP expression and lower pro-inflam-
matory cytokine production than F.n., which may contribute to the
highly virulent nature of F.t. (Figure 7).
Discussion
In this study we demonstrated that miR-155 is highly induced
by F.n. infection and that it targets SHIP to regulate the immune
response against this pathogen. Specifically we have found a novel
role for miR-155 as a positive regulator of pro-inflammatory
cytokine response to Francisella. Over a short period of time, miR-
155 has emerged as an important player in B-cell lymphomas [36],
immune response [24], and other functions [26,37,38]. The
earliest studies of pathogen-induced miR-155 expression examined
the avian leukosis virus (ALV). It was found that ALV induced
high levels of BIC expression in infected chickens and that this was
highly correlated with B-cell lymphoma [39,40]. However, the
most intriguing relationship between miR-155 and viruses is that
both the Kaposi’s-scarcoma-associated herpes virus [41] and the
oncogenic Marek’s disease virus [42] encode functional orthologs
of miR-155. This suggests that miR-155 expression may actually
benefit certain viruses, and one report has supported a role for
miR-155 induction to maintain latent viral genomes through the
negative regulation of an established miR-155 target, IKKe [43].
Deletion of miR-155 leads to system-wide changes in immune
function. For example, B and T cell responses are compromised in
mice genetically deleted for miR-155 [44,45]. MiR-155
2/2 mice
vaccinated with tetanus toxin fragment C showed overall reduced
IgM and switched antigen-specific antibody production from
defects in B-cell function. MiR-155
2/2 T cells also showed
impaired IL-2 and IFNc production after immunization. The T
cells also exhibited a bias toward a TH2 response, possibly due to
the targeting of c-Maf. Antigen presentation is also affected, as
miR-155
2/2 dendritic cells were less able to activate T cells
expressing a transgenic receptor for ovalbumin in the presence of
that protein. Thus, miR-155 serves an essential role in multiple
immune cell types.
Here, we examined the role of miR-155 in monocytes and
macrophages within the context of host response to bacterial
pathogens. Previous studies demonstrated that PI3K/Akt
pathway is host-protective against Francisella infection [18] and
the finding that SHIP negatively regulates this pathway [17] led
us to study the intricacies of SHIP regulation during Francsiella
infection. As the currently-known regulators of SHIP did not
seem to account for all of the changes seen in SHIP expression
[46], we examined the possibility that microRNAs may play a
role. We found that monocytes and macrophages express miR-
155 in response to Francisella infection and that this down-
regulated SHIP. During preparation of this manuscript it was
reported by O’Connell et al. that miR-155 can directly target
SHIP [21]. Our data are consistent with their findings, so the
importance of miR-155 induction in response to Francisella is well
supported.
Multiple TLR ligands are capable of inducing miR-155 [24], so
it is logical that miR-155 induction in response to F.n. requires
TLR2 and MyD88. This finding is of considerable interest because
while there are additional receptors that are engaged and are of
importance in the host response to Francisella, such as the
complement receptor and mannose receptor [47–49], it appears
that MyD88 and the TLR pathway is of critical importance for
miR-155 induction. Downstream of MyD88 activation we found
that ERK and JNK were partly required for miR-155 induction,
which supports the finding by Yiu et al that found ERK- and JNK-
dependent BCR induction of miR-155. In contrast to Yiu et al. but
in agreement with Gatto et al. 2008, who used a viral protein to
induce miR-155 in B-cells, we found that activation of NFkB was
absolutely required for miR-155 induction by Francisella. It is then
fitting that inhibition of PI3K blocked miR-155 induction, as
PI3K controls NFkB activation in response to Francisella. Hence, it
appears as though cell type, cellular context and/or the nature of
stimulus may affect the intracellular machinery involved with miR-
155 expression.
TNFa and IFNb are at least two cytokines produced during
Francisella infection that may contribute to miR-155 induction
[24]. However, it has already been shown that these cytokines
work through the TNFa receptor, while direct TLR stimulation
can induce miR-155 independently of TNFR [24]. This is likely
the case with Francisella, as it has been shown to activate TLR2
[14]. Cytosolic sensing of Francisella by the inflammasome triggers
multiple host response events [33,34]. Given that neither bacterial
internalization nor caspase-1 was clearly required for miR-155
induction, we are lead to conclude that the cytosolic sensing of
Francisella is of marginal importance and that the extracellular
Figure 7. Model of miR-155 induction and function during
Francisella infection. Francisella is recognized on the host cell surface
by TLR2. The signal is transmitted through the adaptor protein MyD88.
Subsequently MAPKs, PI3K and Akt are activated, which leads to
enhanced NFkB activity, inflammatory cytokine production, and
effective host response. SHIP negatively regulates the activation of
Akt to prevent effective host response. During Francisella infection miR-
155 is induced through the TLR signaling pathway, PI3K/Akt, ERK, JNK,
and NFkB. MiR-155 induction in turn down-regulates SHIP to promote
the activation of the PI3K/Akt pathway and inflammatory cytokine
production. The highly virulent F. tularensis suppresses or subverts the
induction of miR-155 in human monocytes, while the relatively avirulent
F. novicida does not.
doi:10.1371/journal.pone.0008508.g007
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induction.
It is important to note that F.t. has been well established to
inhibit host immune response. It has been shown in the mouse that
F.t. does not elicit any inflammatory cytokine production from
dendritic cells [12]. We have previously found that F.t. does elicit
some inflammatory cytokine production from monocytes, but to a
far lesser degree than F.n. [11]. Just recently it has been reported
that the difference in the ability of F.t. to induce inflammatory
cytokine production between human dendritic cells and mono-
cytes is due to differences in CD14 expression on these cells. So
that monocytes which have high CD14 expression are capable of
eliciting some response whereas dendritic cells are not [50]. In any
case, the ability of host cells to mount an effective immune
response to F.t. is impaired by its highly subversive nature.
Finding that the less virulent F.n. can strongly induce miR-155
and down-regulate SHIP whereas the highly virulent F.t. elicits a
suboptimal miR-155 response and an inability to down-regulate
SHIP makes miR-155 of compelling interest for studies of host
response to microbial pathogens. We have recently examined the
mechanisms by which F.t. subverts host response [11] and found
that it preferentially down-regulates both TLR2 and components
of the PI3K/Akt pathway, whereas F.n. does not. This suggests a
mechanism by which F.t. may prevent miR-155 induction, as
TLR2 and PI3K/Akt are components of the miR-155 induction
pathway by Francisella.
In the current study we found that miR-155 positively regulates
TNFa and IL-6 production in response to Francisella. Given that
miR-155 has been shown to target the negative regulator SHIP
and that SHIP negatively regulates NFkB activation and pro-
inflammatory cytokine production, we conclude that miR-155 is
pro-inflammatory within the context of Francisella infection.
Indeed, SHIP has already been shown to negatively regulate
neutrophil responses to TLR2 activation via peptidoglycan [51]
and macrophage responses to Francisella infection [17]. Further,
miR-155 over-expressing mice [52] develop a similar myelopro-
liferative phenotype to that of SHIP
2/2 mice [53]. Hence, it
appears that as with miR-155 expression itself, numerous specific
factors can influence the nature of response to miR-155.
In conclusion, this report demonstrates that miR-155 is induced
by Francisella and that the host response against this pathogen is
enhanced through the targeting of SHIP by miR-155. Further, the
differential induction of miR-155 by virulent versus less virulent
Francisella subspecies suggests that differences in miR responses
may at least partially explain the highly pathogenic nature of F.t.
versus F.n. Further studies are required to determine the exact
cause(s) of this differential response, such as whether it is
completely attributable to TLR2 and PI3K/Akt regulation and
if so, how these are down-regulated by the virulent Francisella.T o
our knowledge, this is the first study to describe differential
regulation of miR-155 by two bacteria of the same subspecies. We




THP-1 cells were obtained from the American Type Culture
Collection (ATCC) (Manassas, VA) and cultured in RPMI-1640
(Gibco-BRL, Rockville, MD) supplemented with 5% heat-
inactivated fetal bovine serum (FBS) (HyClone, Logan, UT), L-
glutamine, penicillin (10,000 U/ml) and streptomycin (10,000 mg/
ml) (Invitrogen, Carlsbad, CA). CHO cells were obtained from
the ATCC and cultured as previously described by [26]. The
BAY7085 IKK inhibitor and Sn50 NFkB peptide inhibitor were a
generous gift from Dr. Denis Guttridge (The Ohio State
University). LY294002 (20 mM), U0126 (2.5 mM) and SP00125
(5 mM) were obtained from Calbiochem (San Diego, CA).
SB203580 (5 mM) and DMSO vehicle control (0.2%) was
obtained from Sigma-Aldrich (St. Louis, MO). Cytochalasin-D
was purchased from Biosource (Camarillo, CA) and used at a
concentration of 5 mg/ml.
Transgenic and Knockout Mice
The C57BL/6J wild-type and TLR2 signaling mutant mice
(TLR2
tm1kir/J) were obtained from The Jackson Laboratory
(Bar Harbor, MA). Wild-type and miR-155
2/2 (B6.129S7-
Mirn155
tm1Brd) mice were obtained from Mutant Mouse Regional
Resource Centers (MMRRC) (Columbia, MO).
Bone Marrow-Derived Macrophages
Mice were sacrificed and the femurs were removed. Bone
marrow was flushed from the femurs and the cells were cultured in
DMEM (Invitrogen, Carlsbad, CA) with 10% heat-inactivated
FBS, 30% sterile filtered L-cell conditioned media, 0.1% b-
mercaptoethanol (BioRad, Hercules, CA), and penicillin/strepto-
mycin for six to seven days. The murine fibroblast cell line L929
was a generous gift from Dr. Ste ´phanie Seveau (The Ohio State
University). L929 cells were grown to confluence in minimum
essential media (Invitrogen, Carlsbad, CA) supplemented with
10% heat-inactivated FBS (HyClone, Logan, UT), non-essential
amino acids, sodium pyruvate and penicillin/streptomycin
(Invitrogen, Carlsbad, CA). Conditioned media from the L929
cells was collected, passed through a 0.2 mm filter and used to
supplement the murine macrophage cultures. After 6 to 7 days of
culture, BMM were washed 3 times in sterile PBS, scraped, then
plated overnight in 12-well tissue culture plates. Purity of
harvested macrophages was verified though CD11b
+ staining by
flow cytometry.
Peripheral Blood Monocyte Isolation
Human peripheral blood monocytes (PBM) were isolated by
centrifugation through a Ficoll gradient followed by CD14-positive
Magnet-Assisted Cell Sorting (MACS, Miltenyi Biotec, Auburn,
CA) according to manufacturer instructions as previously described
[11]. Flow cytometry using CD14 antibody showed a minimum of
98% purity for each sample. PBM were maintained in RPMI-1640
containing 10% heat-inactivated FBS and L-glutamine.
Bacterial Infections
All infections were conducted in 5% or 10% FBS-containing
RPMI-1640 without antibiotic. F. novicida U112 (JSG1819) and F.
tularensis subspecies tularensis (SCHU S4) were generously provided
by Dr. John Gunn (OSU), and grown on Chocolate II agar plates
(Becton, Dickinson and Company, Sparks, MD) at 37uC. SCHU
S4 infections were conducted by CDC approved select agent users
at The Ohio State University BSL3 Select Agent facility in
accordance with the BSL3 bio-safety plan. All SCHU S4 strain
infected samples and matched reference samples were decontam-
inated in accordance with approved protocols by the BSL3
advisory committee to ensure effective killing of microbes before
removal from the facility. MOI was determined by optical density
at 600 nm and verified by plating the inoculum overnight and
counting CFU as done previously [11]. Heat-killed F.t. novicida
were prepared by heating at 98uC for 10 minutes. Paraformalde-
hyde (PFA)-killed F.n. were prepared by treating with 4% PFA for
30 minutes and then washing with PBS three times to remove
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chocolate II agar to ensure effective killing. Pulse-chase infections
were done by infecting for 2 hours, removing the media, washing
the cells with sterile PBS, and then incubating in media containing
50 mg/ml gentamicin (Invitrogen, Carlsbad, CA) for 30 minutes.
Cells were then washed again and incubated in media containing
10 mg/ml gentamicin for the duration of the experiments.
In Vivo Challenge with F.n.
Wild-type mice were injected intraperitoneally with either
200 CFU of F.n. or PBS in accordance with institutional animal
use protocols. The infectious dose was verified by CFU assays.
Mice were euthanized at 24, 48 or 72 hours post-infection. The
liver, lungs, and spleen were harvested, passed though a 70 mm
cell strainer (BD, Bedford, MA), centrifuged briefly and then
resuspended in TRIzolH reagent (Invitrogen, Carlsbad, CA). RNA
extraction was then performed according to manufacturer
instructions (Invitrogen).
ELISA Cytokine Measurements
Sandwich ELISAs were done for human TNFa using kits from
R&D Systems (Minneapolis, MN) and for human IL-1b using kits
from eBioscience (San Diego, CA) as done previously [17].
Western Blot Analysis
Cells were lysed in TN1 buffer (50 mM Tris [pH 8.0], 10 nm
EDTA, 10 M Na4P2O7, 10 nM NaF, 1% Triton-X 100, 125 nM
NaCl, 10 nM Na3VO4,1 0mg/ml of both aprotinin and leupeptin.
Proteins were electrophoretically separated on 10% acrylamide
gels, tranferred to nitrocellulose membranes and then probed with
rabbit polyclonal anti-mouse SHIP (generously provided by Dr. K.
Mark Coggeshall) or anti-human SHIP (Upstate Cell Signaling
Solution, Lake Placid, NY). Goat polyclonal antibody against actin
was purchased from Santa Cruz Biotechnology (Santa Cruz, CA).
Rabbit antibodies against pIKKa and NFkBp65 were purchased
from Cell Signaling (Beverly, MA). Detections were performed
using HRP-conjugated secondary antibodies followed by en-
hanced chemiluminescence (GE, Buckinghamshire, UK) as
previously described [17].
Real-Time PCR
Cells were lysed in TRIzolH reagent (Invitrogen, Carlsbad, CA)
and RNA isolation was completed according to the manufacturer’s
instructions. 10 to 100 ng of total RNA were used for reverse
transcription as measured by a ND-1000 spectrophotometer
(Nanodrop, Wilmington, DE). cDNA was made using the
TaqManH MicroRNA Reverse Transcription Kit (Applied
Biosystems, Foster City, CA) and the specific reverse transcription
primers for hsa-miR-155, mmu-miR-155, and the housekeeping
genes RNU44 and RNU48 (human), sno412 and sno202 (mouse)
(Applied Biosystems, Foster City, CA). The corresponding PCR
primers were used with TaqManH Universal PCR Master Mix, No
AmpEraseH UNG (Applied Biosystems, Branchburg, NJ) using an
ABI PRISM 7900HT Fast PCR system. cDNA for BIC mRNA
expression was primed for reverse transcription with 0.8 nM of
random hexamer (Applied Biosystems, Foster City, CA) and
analyzed by qRT-PCR using custom Taqman probes spanning
exons 2–3 (Hs01374570) (Applied Biosystems, Foster City, CA).
Control reactions containing no reverse transcriptase and no
cDNA template were also performed. Samples were measured
in triplicate for each experiment, and each experiment was
performed at least 3 times. Relative expression was calculated
as 2ˆ2(CT Target2CT Housekeeping Gene) and significance was
determined by a paired Student t test [26]. To simplify data
presentation, relative expression values were converted to fold
change over uninfected.
Transfection
5 mg of pcDNA3.1 vector with or without exon 3 of human BIC
was used for each transfection with 10610
6 PBM. Amaxa solution
T was used for electroporation using program Y-01 as previously
described [18]. Infections were performed 14 hours post-transfec-
tion. Optimal miR-155 expression was found between 12 and
14 hours post-transfection by qRT-PCR analysis. Cell viability
was monitored by trypan blue staining. At this time approximately
70% of the original PBM were recovered/viable and the numbers
were comparable in vector versus miR-155 transfected cells.
Construction of psiCHECK/INPP5D
A fragment encompassing the INPP5D 39UTR was PCR-
amplified using the forward primer (59-.AGC CCT CAG TGA
GCT GCC ACT GAG TCG -.39) and reverse primer (59-
.GAG TGA GAA AGG CAC AAT TTA ATT GG-.39). This
was subcloned into the PCR2.1 vector following the manufactur-
er’s protocol (Invitrogen). Plasmid DNA was isolated from
transformed colonies and verified by dideoxy chain termination
sequencing. The fragment was removed from the PCR2.1 plasmid
by digestion with EcoRI and blunt-end ligated into the psiCHECK
vector downstream of the f-luc reporter gene. The final construct
was verified by dideoxy chain termination sequencing.
Luciferase Reporter Assay
Dual-luciferase reporter assays were done using the psiCHECK
vector with or without the 39 UTR of SHIP, cotransfected with
50 ng of the pRL-CMV Renilla luciferase vector (Promega,
Madison, WI). CHO cells were transfected with 0 to 50 nM
synthetic miR precursor of miR-155 or scrambled miR control
(Ambion) and luciferase reporter vectors using lipofectamine 2000
(Invitrogen, Carlsbad, CA). 48 hours post transfection cells were
lysed with passive lysis buffer (Promega) and dual-luciferase activity
was assayed using a luminometer as previously described [26].
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